Clinical Trial Update: Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is recruiting to test whether metformin can alleviate statin-induced abnormal glucose metabolism in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Statins
• metformin (metformin)

Snippet

Sponsor: Central South University | Conditions: Schizophrenia | Phase 3 | Status: RECRUITING